Fresenius Medical Care revenue and financials
€40.45Change from previous close: +0.70%Absolute change: +€0.28
In the fiscal year ended December 2025, Fresenius Medical Care reported revenue of €19.63B (+1.51% year over year). Net income was €978.37M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +1.51%
- 2025 vs 2024
- Net income growth
- +81.88%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 2.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4,861 | 4,612 | 5,070 | 4,885 | 4,792 | 4,881 | 5,085 | 4,760 | 4,766 | 4,725 | 4,988 | 4,936 |
| Cost of revenue | 3,551 | 3,433 | 3,681 | 3,643 | 3,577 | 3,697 | 3,814 | 3,614 | 3,600 | 3,551 | 3,638 | 3,707 |
| Gross profit | 1,310 | 1,179 | 1,388 | 1,242 | 1,214 | 1,184 | 1,270 | 1,146 | 1,166 | 1,174 | 1,350 | 1,229 |
| Selling, general and administrative | 736 | 749 | 785 | 705 | 792 | 751 | 840 | 756 | 771 | 776 | 845 | 794 |
| Research and development | 39.6 | 38.3 | 38.6 | 37.7 | 38.1 | 43.5 | 50.1 | 40.0 | 45.6 | 47.8 | 66.0 | 53.0 |
| Operating income | 524 | 376 | 592 | 502 | 394 | 382 | 409 | 396 | 373 | 361 | 495 | 364 |
| EBIT | 524 | 376 | 592 | 502 | 394 | 382 | 409 | 396 | 373 | 361 | 495 | 364 |
| EBITDA | 879 | 728 | 780 | 854 | 750 | 758 | 610 | 762 | 745 | 749 | 709 | 751 |
| Interest expense | 97.6 | 93.3 | 99.0 | 93.1 | 96.6 | 95.7 | 101 | 99.1 | 103 | 104 | 111 | 114 |
| Pre-tax income | 383 | 208 | 508 | 403 | 351 | 251 | 179 | 381 | 339 | 158 | 343 | 236 |
| Income tax | 89.8 | 42.8 | 106 | 75.2 | 78.3 | 61.0 | 61.0 | 117 | 99.0 | 39.5 | 86.5 | 88.5 |
| Net income | 218 | 118 | 327 | 275 | 225 | 151 | 66.9 | 213 | 187 | 71.0 | 188 | 84.4 |
| Net income to common shareholders | 218 | 118 | 327 | 275 | 225 | 151 | 66.9 | 213 | 187 | 71.0 | 188 | 84.4 |
| Basic EPS | 0.81 | 0.43 | 1.14 | 0.94 | 0.77 | 0.52 | 0.23 | 0.73 | 0.64 | 0.24 | 0.64 | 0.29 |
| Diluted EPS | 0.81 | 0.43 | 1.14 | 0.94 | 0.77 | 0.52 | 0.22 | 0.73 | 0.64 | 0.24 | 0.64 | 0.29 |
| Average shares (basic) | 268 | 275 | 286 | 292 | 293 | 293 | 293 | 293 | 293 | 293 | 293 | 293 |
| Average shares (diluted) | 268 | 275 | 286 | 292 | 293 | 293 | 293 | 293 | 293 | 293 | 293 | 293 |
| Dividend per share | — | — | 1.49 | — | — | — | 1.44 | — | — | — | 1.19 | — |